Chronic progressive multiple sclerosis: genes and variants
Explore variant evidence for Chronic progressive multiple sclerosis across 1 analyzed protein (HNRNPA1). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Chronic progressive multiple sclerosis
HNRNPA1: Heterogeneous nuclear ribonucleoprotein A1
It regulates pre-mRNA splicing, RNA transport, translation, and stress-granule dynamics through RNA binding and reversible self-assembly. Rare pathogenic variants can cause multisystem proteinopathy, amyotrophic lateral sclerosis, or related neuromuscular degeneration through altered RNA and protein homeostasis.
14 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in HNRNPA1 have source records linked to Chronic progressive multiple sclerosis. Association strength is not clinical gene validity.
Where Chronic progressive multiple sclerosis variants cluster
- HNRNPA1 Nuclear targeting sequence (M9) (positions 320–357): 12 of 14 ClinVar pathogenic / likely pathogenic variants, 8.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Chronic progressive multiple sclerosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HNRNPA1 F325V | 325 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 F325L | 325 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 N353D | 353 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 P327S | 327 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 R336G | 336 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 P351L | 351 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 N353S | 353 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 K329N | 329 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 F333L | 333 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 F348L | 348 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 F315L | 315 | Pathogenic / likely pathogenic | |
| HNRNPA1 N317D | 317 | Pathogenic / likely pathogenic | |
| HNRNPA1 S337G | 337 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 Y347C | 347 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
Which prediction tools work for Chronic progressive multiple sclerosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 77 out of 100
- SIFT: 60 out of 100
- CATVariant: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 44 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 42 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 41 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 30 out of 100
Diseases related to Chronic progressive multiple sclerosis
- Amyotrophic lateral sclerosis, also linked to HNRNPA1
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia, also linked to HNRNPA1
- Relapsing remitting multiple sclerosis, also linked to HNRNPA1
Frequently asked questions
Which genes have records linked to Chronic progressive multiple sclerosis?
This view contains 1 analyzed proteins: HNRNPA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 19 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center